1.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CCBX001-049, NCT00078598
|
|
2.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: J0703, NA00005743, NCT00484874
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 59
Sponsor: NCI
Protocol IDs: FHCRC-1368.00, NCT00073918
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-S0433, NCT00107380, S0433
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2005.035, NCT00135200
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GSK Protocol #109407, NCT00475332
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: PSOC 2301, IR-6466, NCT00476047
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: LYMNHL0019, 95337, LYMNHL0019, NCT00490009, NCT00490009
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 19 and over
Sponsor: Other
Protocol IDs: LYMNHL0046, 97437, LYMNHL0046, NCT00490490, NCT00490490
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: FHCRC-1943.00, NCT00110071
|
|
11.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UMCC 2006.045, NCT00398762
|
|
12.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: UPCC 18406, UPenn IRB#805353, GSK 106665, NCT00434629
|
|
13.
|
Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 100
Sponsor: NCI
Protocol IDs: JHOC-J0636, NCT00416312
|
